Skip to Content

CPC2635 (Theracaps Multi-Symptom Cough & Cold Reliever acetaminophen 500 mg / chlorpheniramine maleate 2 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 30 mg)

Pill with imprint CPC2635 is Orange, Round and has been identified as Theracaps Multi-Symptom Cough & Cold Reliever acetaminophen 500 mg / chlorpheniramine maleate 2 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 30 mg. It is supplied by Reese Pharmaceutical Company.

Acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine is used in the treatment of cold symptoms; influenza and belongs to the drug class upper respiratory combinations. FDA has not classified the drug for risk during pregnancy. Acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine acetaminophen 500 mg / chlorpheniramine maleate 2 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CPC2635

Theracaps Multi-Symptom Cough & Cold Reliever

Imprint
CPC2635
Strength
acetaminophen 500 mg / chlorpheniramine maleate 2 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 30 mg
Color
Orange
Shape
Round
Availability
Over the counter
Drug Class
Upper respiratory combinations
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Reese Pharmaceutical Company
National Drug Code (NDC)
10956-0772

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.